URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1
|
disease |
|
Finding
|
1
|
2
|
0.600 |
limited |
1.000 |
1 |
2
|
2016 |
2016 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
644
|
23
|
0.310 |
None |
1.000 |
1 |
|
2009 |
2009 |
Mammary Neoplasms, Experimental
|
phenotype |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
218
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Adenoma, Monomorphic
|
disease |
Neoplasms
|
Neoplastic Process
|
36
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Papillary adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
39
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Adenoma, Trabecular
|
disease |
Neoplasms
|
Neoplastic Process
|
37
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
977
|
39
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Secondary Biliary Cholangitis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
42
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Adenoma, Microcystic
|
disease |
Neoplasms
|
Neoplastic Process
|
45
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Follicular adenoma
|
disease |
Neoplasms
|
Neoplastic Process
|
183
|
5
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Adenoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
49
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
132
|
36
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Biliary Cirrhosis, Primary, 1
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
42
|
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
2723
|
2387
|
0.300 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Primary biliary cirrhosis
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
478
|
667
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hyperparathyroidism, Secondary
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
68
|
4
|
0.210 |
None |
1.000 |
1 |
|
2017 |
2017 |
Injury of liver
|
disease |
Digestive System Diseases; Wounds and Injuries
|
Injury or Poisoning
|
36
|
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |